• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarUSA Market OverviewCanada Market OverviewEurope Market Overview
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Swing Trading Course
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of BGLC

BIONEXUS GENE LAB CORP (BGLC) Stock News

USA - NASDAQ:BGLC - US0906283066 - Common Stock

5.3 USD
+0.1 (+1.92%)
Last: 10/22/2025, 2:32:46 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

BGLC Latest News, Press Relases and Analysis

All
Press Releases
2 days ago - By: Benzinga - Mentions: ACCL FGI LIQT YGMZ ...
News Image

12 Industrials Stocks Moving In Monday's Pre-Market Session

2 days ago - By: BioNexus Gene Lab Corp.
News Image

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

2 days ago - By: BioNexus Gene Lab Corp.
News Image

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

a month ago - By: Benzinga - Mentions: JOB AERT MWG CREG ...
News Image

12 Industrials Stocks Moving In Friday's After-Market Session

3 months ago - By: BioNexus Gene Lab Corp.
News Image

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology